Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro

Alexander Gorshtein(Rabin Medical Center), Ilan Shimon(Tel Aviv University)
Endocrine Related Cancer
June 9, 2009
Cited by 78


Related Papers

High Glucose Variability Increases Mortality Risk in Hospitalized Patients
|The Journal of Clinical Endocrinology & Metabolism|2017|66